4G Clinical
PrivateLast Round
Growth Equity
Jun 29, 2021
Total Funding Raised
$252.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
4G Clinical is a healthtech company that provides a cloud-based randomization and trial supply management (RTSM) platform for the life sciences industry.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Pharma Supply Chain, Vertical SaaS, Supply Chain
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
4G Clinical Comparables
Compare 4G Clinical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Suvoda | 91% | |
| Dassault Systèmes | 84% | |
| Oracle Solaris | 83% |
4G Clinical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Jun 29, 2021 | ||||
| Series B | Jan 29, 2020 | ||||
| Series A Extension | Oct 19, 2016 | ||||
| Series A | Jan 29, 2016 |
Key People
Founding team and executive leadership
4G Clinical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| First Analysis | Series B |
| Goldman Sachs Asset Management Private Equity | Growth Equity |
| Schooner Capital | Series B, Series A, Series A Extension |
| Goldman Sachs Growth Equity | Growth Equity |
| Goldman Sachs & Co. LLC | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 190, 47% of headcount.
- Jul 13, 2026
Open roles increased to 94, 8.2x the trailing average.
4G Clinical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about 4G Clinical's valuation, stock price, and market status.
Is 4G Clinical a public or private company?
4G Clinical is a private company.
What is the current stock price of 4G Clinical?
4G Clinical is a private company with no public stock price. No recent secondary market data is available.
How much is 4G Clinical worth (valuation)?
Valuation information for 4G Clinical is not publicly available.
Can I buy 4G Clinical stock?
4G Clinical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was 4G Clinical's last funding round?
4G Clinical's most recent funding round was Growth Equity on June 29, 2021.
Who are the main investors in 4G Clinical?
Key investors in 4G Clinical include Schooner Capital, Goldman Sachs Growth Equity, Goldman Sachs & Co. LLC.
Will 4G Clinical IPO soon?
No public IPO plans have been announced for 4G Clinical.
How can I track 4G Clinical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 4G Clinical's secondary market activity and sign up for updates.